美國青蒿素酸市場規模、佔有率和趨勢分析報告：按產品和細分市場預測（2025-2033 年）

美國青蒿素酸市場摘要

2024年美國青蒿素酸市場規模估計為2.366億美元，預計2033年將達到3.677億美元。

預計從 2025 年到 2033 年，該市場將以 5.0% 的複合年成長率成長。美國青蒿素酸市場的主要成長要素包括：與國際旅行相關的瘧疾病例增加、全球對傳統抗瘧疾藥的抗藥性日益增強、政府支持的儲備舉措以及半合成生產方法的研究和開發不斷擴大。

非洲和東南亞地區惡性瘧疾原蟲對傳統抗瘧疾藥抗藥性株的出現，促使醫療機構和政策制定者優先考慮快速起效的青蒿素類藥物治療。隨著抗藥性模式的演變，美國越來越依賴效力更強的青蒿素製劑，推動進口、研發投資和有效治療藥物儲備，以確保能夠應對毒性更強的瘧疾。

此外，基因改造酵母（釀酒酵母）等生物技術創新使得青蒿素酸的生產更加可靠和大規模，從而減少了對易受氣候變遷和產量波動影響的艾蒿（青蒿）等農業原料的依賴。隨著製藥公司採用這些方法，美國市場將受益於更可靠、更具成本效益的生產，從而支援更廣泛的分銷和緊急準備。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國青蒿素酸市場趨勢及展望

• 市場體系展望
  • 母市場
  • 子公司市場
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 美國青蒿素酸市場分析工具
  • 產業分析—波特五力分析
  • PESTEL 分析
  • 法律規範

第4章美國青蒿素酸市場：依產品分類的估算與趨勢分析

• 細分儀表板
• 美國青蒿素酸市場：按產品分類的波動分析
• 美國青蒿素酸市場規模及趨勢分析（依產品分類，2021-2033 年）
• 抗瘧疾藥片
• 抗瘧疾注射劑

第5章 競爭情勢

• 市場參與企業分類
• 企業市場分析/堆圖分析
• 公司簡介
  • Sanofi
  • KPC Pharmaceuticals, Inc.
  • Guilin Pharmaceuticals Co,. Ltd.
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis Pharmaceuticals Corporation
  • Ipca Laboratories Inc.
  • Cipla USA Inc.
  • SHINPOONG CO. Ltd.

U.S. Artemisinic Acid Market Summary

The U.S. artemisinic acid market size was estimated at USD 236.6 million in 2024 and is projected to reach USD 367.7 million by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The primary factors driving the U.S. artemisinic acid market include an increase in malaria cases connected to international travel, the rising global resistance to traditional antimalarials, government-supported stockpiling initiatives, and expanded research and development in semi-synthetic production methods.

The rise of Plasmodium falciparum strains resistant to traditional antimalarial drugs in Africa and Southeast Asia is prompting healthcare providers and policymakers to prioritize access to fast-acting artemisinin-based treatments. As resistance patterns evolve, U.S. institutions increase their reliance on advanced artemisinic formulations, driving imports, R&D investment, and stockpiling of effective therapies to ensure readiness against more virulent malaria forms.

Furthermore, biotechnology innovations such as engineered Saccharomyces cerevisiae (yeast)-have enabled more stable and scalable production of artemisinic acid. This reduces reliance on agricultural sources such as Artemisia annua, vulnerable to climate and yield variability. As pharmaceutical companies adopt these methods, the U.S. market benefits from enhanced production reliability and cost-efficiency, supporting broader distribution and emergency preparedness.

U.S. Artemisinic Acid Market Report Segmentation

This report forecasts revenue growth at U.S. artemisinic acid market and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artemisinic acid market report based on product.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Antimalarial Injections
• Antimalarial Tablets

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. U.S. Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Artemisinic Acid Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. Artemisinic Acid Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework

Chapter 4. U.S. Artemisinic Acid Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artemisinic Acid Market: Product Movement Analysis
• 4.3. U.S. Artemisinic Acid Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
• 4.4. Antimalarial Tablets
  • 4.4.1. Antimalarial Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Antimalarial Injections
  • 4.5.1. Antimalarial Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Company Market Position Analysis/ Heap Map Analysis
• 5.3. Company Profiles
  • 5.3.1. Sanofi
    • 5.3.1.1. Participant's Overview
    • 5.3.1.2. Financial Performance
    • 5.3.1.3. Product Benchmarking
    • 5.3.1.4. Strategic Initiatives
  • 5.3.2. KPC Pharmaceuticals, Inc.
    • 5.3.2.1. Participant's Overview
    • 5.3.2.2. Financial Performance
    • 5.3.2.3. Product Benchmarking
    • 5.3.2.4. Strategic Initiatives
  • 5.3.3. Guilin Pharmaceuticals Co,. Ltd.
    • 5.3.3.1. Participant's Overview
    • 5.3.3.2. Financial Performance
    • 5.3.3.3. Product Benchmarking
    • 5.3.3.4. Strategic Initiatives
  • 5.3.4. Calyx Chemicals and Pharmaceuticals Ltd.
    • 5.3.4.1. Participant's Overview
    • 5.3.4.2. Financial Performance
    • 5.3.4.3. Product Benchmarking
    • 5.3.4.4. Strategic Initiatives
  • 5.3.5. Novartis Pharmaceuticals Corporation
    • 5.3.5.1. Participant's Overview
    • 5.3.5.2. Financial Performance
    • 5.3.5.3. Product Benchmarking
    • 5.3.5.4. Strategic Initiatives
  • 5.3.6. Ipca Laboratories Inc.
    • 5.3.6.1. Participant's Overview
    • 5.3.6.2. Financial Performance
    • 5.3.6.3. Product Benchmarking
    • 5.3.6.4. Strategic Initiatives
  • 5.3.7. Cipla USA Inc.
    • 5.3.7.1. Participant's Overview
    • 5.3.7.2. Financial Performance
    • 5.3.7.3. Product Benchmarking
    • 5.3.7.4. Strategic Initiatives
  • 5.3.8. SHINPOONG CO. Ltd.
    • 5.3.8.1. Participant's Overview
    • 5.3.8.2. Financial Performance
    • 5.3.8.3. Product Benchmarking
    • 5.3.8.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Artemisinic Acid Market, by Product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. artemisinic acid market revenue, 2021 - 2033 (USD Million)
• Fig. 10 U.S. artemisinic acid market snapshot
• Fig. 11 U.S. artemisinic acid market driver impact
• Fig. 12 U.S. artemisinic acid market restraint impact
• Fig. 13 U.S. artemisinic acid market product key takeaways (USD Million)
• Fig. 14 U.S. artemisinic acid market : Product movement analysis
• Fig. 15 Antimalarial injections market, 2021 - 2033 (USD Million)
• Fig. 16 Antimalarial tablets market, 2021 - 2033 (USD Million)
• Fig. 17 Market participant categorization